Back to search

University of Ioannina

Αποκωδικοποιώντας τον αιτιολογικό και προγνωστικό χάρτη των πνευμονολογικών νόσων

Abstract

dc:description

The aim of this PhD thesis was to decipher the etiologic and prognostic factors related to two chronic respiratory diseases that have remarkable morbidity and mortality, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The first aim of the thesis was to critically appraise the epidemiological credibility of COPD and, to this end, an umbrella review was conducted. A systematic search was performed, to capture systematic reviews and meta-analyses of observational studies on environmental factors and biomarkers for risk of COPD. A set of standardised methodological criteria was applied, based on the level of statistical significance, sample size, between-study heterogeneity and statistical biases. The search yielded 11 eligible papers, including 18 meta-analyses, and 8 eligible papers, that did not perform qualitative synthesis. Eleven associations achieved statistical significance at P < 0.001, thirteen associations presented an I2 >50%, while six associations had evidence of small-study effects and/or excess significance bias. History of tuberculosis or rheumatoid arthritis, exposure to biomass fuels, tobacco smoking and second hand smoking were supported by high epidemiological credibility for an increased risk of COPD. Moreover, highly suggestive evidence was found for increased levels of serum C-reactive protein, and serum fibrinogen in COPD patients compared with healthy controls. To summarize, findings suggests that, while a proportion of COPD patients are non-smokers, only a narrow range of risk factors not related to smoking have been studied for an association with COPD. Furthermore, there is a need to decipher possible protective factors in COPD pathogenesis given that more than a half of ever-smokers do not develop COPD.The second aim of the thesis was to map and assess prognostic models for outcome prediction in patients with COPD. A systematic review was conducted, through a literature search in PubMed until November 2018, and the search was complemented by hand searching references from eligible articles. Eligible articles included studies developing, validating, or updating a prediction model in COPD patients, foccusing on any potential clinical outcome. The systematic search yielded 228 eligible articles, describing the development of 408 prognostic models, the external validation of 38 models, and the validation of 20 prognostic models derived for diseases other than COPD. The 408 prognostic models were developed in three clinical settings: outpatients (239 prognostic models; 59%), patients admitted to hospital (155 prognostic models; 38%), and patients attending the emergency department (14 prognostic models; 3%). Among the 408 prognostic models, the most prevalent outcomes were mortality (209 prognostic models; 51%), risk for acute exacerbation of COPD (42 prognostic models; 10%), and risk for readmission after the index hospital admission (36 prognostic models; 9%). Overall, the most frequently used predictors were age (166 prognostic models; 41%), forced expiratory volume in one second (85 prognostic models; 21%), sex (74 prognostic models; 18%), body mass index (66 prognostic models; 16%), and smoking (65 prognostic models; 16%). . Model discrimination using the C statistic was available for 311 (76%) models, while calibration was examined in 91 (23%) of the developed models. Of the 408 prognostic models, 100 (25%) were internally validated. For 286 (70%) models a model presentation was not available, and only 56 (14%) models were presented through the full equation. 38 models were externally validated, but in only 12 of thesethe validation was performed by a fully independent team. Seven prognostic models were assessed with an overall low risk of bias according to PROBAST. These models were ADO, B-AE-D, B-AE-D-C, extended ADO, updated ADO, updated BODE, and a model developed by Bertens et al. A meta-analysis of C statistics was performed for 12 prognostic models, and the summary estimates ranged from 0.611 to 0.769.The findings of the systematic review indicated several methodological pitfalls in the development of prognostic models and a low rate of external validation. Future research should focus on the improvement of existing models through update and external validation, as well as the assessment of the safety, clinical effectiveness, and cost effectiveness of the application of these prognostic models in clinical practice through impact studies.The third aim of the PhD thesis was to examine the association of smoking-related exposures with risk of IPF and potential interaction between them. A prospective cohort study was conducted in UK Biobank, including 437,453 non-related men and women of white ethnic background (aged 40 to 69 at baseline). The effect of tobacco smoking-related exposures on risk for IPF was assessed using Cox regression adjusted for age, sex, Townsend deprivation index, and home area population density. Potential additive and multiplicative interaction was examined between these exposures. Multiple imputation with chained equations was used to deal with missing data. 802 incident IPF cases were identified. An association between smoking status (HR, 2.12; 95% CI, 1.81-2.47) and maternal smoking (HR, 1.38; 95% CI, 1.18-1.62) was depicted with risk for IPF in the multivariable model. In ever smokers, a dose-response relationship was observed between pack-years of smoking and risk of IPF (HR per 1 pack-year increase, 1.013; 95% CI, 1.009-1.016). Furthermore, an additive and multiplicative interaction was observed between maternal smoking and smoking status with a relative excess risk due to interaction of 1.00 (95% CI, 0.45-1.54) and a ratio of HR of 1.50 (95% CI, 1.05-2.14). To sum up, active and maternal tobacco smoking have a detrimental effect on risk of IPF and work synergistically. Also, intensity of smoking presents a dose-response association with IPF, strengthening the hypothesis for a potentially causal association.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bellou, Vaia-Vanesa
  • Μπέλλου, Βάια-Βανέσα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50296

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bellou, Vaia-Vanesa; Μπέλλου, Βάια-Βανέσα. Αποκωδικοποιώντας τον αιτιολογικό και προγνωστικό χάρτη των πνευμονολογικών νόσων. University of Ioannina, 2021. http://hdl.handle.net/10442/hedi/50296